Ernexa Therapeutics (ERNAW) Interest & Investment Income (2023 - 2026)
Ernexa Therapeutics (ERNAW) reported Interest & Investment Income of $44000.0 for Q1 2026, up 780.0% on a YoY basis from $5000.0 in Q1 2025, and up 169.84% quarter-over-quarter from -$63000.0 in Q4 2025.
Ernexa Therapeutics (ERNAW) Interest & Investment Income (2023 - 2026) Analysis & Trends
Ernexa Therapeutics has reported Interest & Investment Income for 4 years, with the latest figure at $44000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 780.0% year-over-year to $44000.0; the trailing twelve-month figure through Mar 2026 stood at $12000.0 (down 98.85% YoY), and the FY2025 full-year result was -$27000.0, down 110.84% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $44000.0, up from -$63000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $3.5 million in Q4 2024, with the low at -$1.7 million in Q3 2024.
- Historically, Interest & Investment Income has averaged $33666.7 across 4 years, with a median of $3000.0 in 2023.
- The largest YoY upside for Interest & Investment Income was 1456.64% in 2024 against a maximum downside of 78700.0% in 2024.
- Ernexa Therapeutics' Interest & Investment Income stood at $226000.0 in 2023, then surged by 1456.64% to $3.5 million in 2024, then tumbled by 101.79% to -$63000.0 in 2025, then jumped by 169.84% to $44000.0 in 2026.
- The last three Interest & Investment Income figures came in at $44000.0 (Q1 2026), -$63000.0 (Q4 2025), and $31000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Ernexa Therapeutics | - | - | - | 44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 3.52 Mn |
| Sep 30, 2024 | -1.69 Mn |
| Jun 30, 2024 | -797,000.00 |
| Mar 31, 2024 | -786,000.00 |
| Dec 31, 2023 | 226,000.00 |
| Sep 30, 2023 | -113,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Mar 31, 2023 | 1,000.00 |